Company Filing History:
Years Active: 2012
Title: Bénédicte Menn: Innovator in Neurological Disease Treatment
Introduction
Bénédicte Menn is a prominent inventor based in Marseilles, France. She has made significant contributions to the field of medicine, particularly in the treatment of neurological diseases. Her innovative work has led to the development of a unique medication aimed at protecting against and treating various neurological conditions.
Latest Patents
Bénédicte Menn holds a patent for the administration of (S)-roscovitine for protection against and/or treatment of neurological diseases. This invention relates to the use of 6-(benzyl-amino)-2(S)-[[1-(hydroxymethyl) propyl]amino]-9-isopropylpurine or its pharmaceutical acceptable salts for manufacturing a medication intended for the prevention and/or treatment of neurological diseases, especially those associated with neurological lesions. She has 1 patent to her name.
Career Highlights
Bénédicte Menn has established herself as a key figure in her field through her innovative research and development efforts. She works at Neurokin, a company dedicated to advancing treatments for neurological disorders. Her work has garnered attention for its potential impact on patient care and treatment outcomes.
Collaborations
Bénédicte has collaborated with notable professionals in her field, including Serge Timsit and Laurent Meijer. These partnerships have enhanced her research and contributed to the advancement of her innovative projects.
Conclusion
Bénédicte Menn is a trailblazer in the realm of neurological disease treatment, with her patent showcasing her commitment to improving patient health. Her work at Neurokin and collaborations with esteemed colleagues further highlight her significant contributions to medical science.